M. Cohen, M. Mccauley, and T. Gamble, HIV treatment as prevention and HPTN 052, Current Opinion in HIV and AIDS, vol.7, issue.2, pp.99-105, 2012.
DOI : 10.1097/COH.0b013e32834f5cf2

V. Supervie, . Epidémie, and . France, Les derniers chiffres et pistes pour le dépistage. 20 ans de lapremì ere publication de la FHDH, 2012.

V. Supervie, Les nouvelles estimations de la population non diagnostiquée pour le VIH en France. Les séminaires de recherche de l'ANRS, 2012.

C. Sloan, K. Champenois, P. Choisy, E. Losina, R. Walensky et al., Newer drugs and earlier treatment, AIDS, vol.26, issue.1, p.2012
DOI : 10.1097/QAD.0b013e32834dce6e
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237010

S. Lodi, A. Phillips, G. Touloumi, R. Geskus, L. Meyer et al., Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm3: assessment of need following changes in treatment guidelines Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 6 ART Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies, Lancet, vol.53, issue.3729635, pp.817-825293, 2008.

R. Baggaley, R. White, T. Hollingsworth, and M. Boily, Heterosexual HIV-1 Infectiousness and Antiretroviral Use, Epidemiology, vol.24, issue.1, p.2013
DOI : 10.1097/EDE.0b013e318276cad7

D. Romero, J. Castilla, J. Hernando, V. Rodriguez, C. Garcia et al., Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study, BMJ, vol.340, issue.may14 1, p.2205, 2010.
DOI : 10.1136/bmj.c2205